Abstract:The respiratory epithelium constitutes the physical barrier between the human body and the environment, thus providing functional and immunological protection. It is often exposed to allergens, microbial substances, pathogens, pollutants, and environmental toxins, which lead to dysregulation of the epithelial barrier and result in the chronic inflammation seen in allergic diseases and asthma. This epithelial barrier dysfunction results from the disturbed tight junction formation, which are multi-protein subuni… Show more
“…Mouse model of asthma is characterized with AAI developed with i.p OVA sensitization and i.n challenge with OVA in BALB/c mice. This model is characterized by airway inflammation associated with increased type 2 lymphocytes infiltration, eosinophils, alveolar epithelial barrier damage, and mucus secretion by epithelial goblet cells, [2,15,16,32,33] however, the inflammatory manifestations in the gut in not well studied. As observed in several previous studies highlighted the importance of Th2 responses in both gut and lung, we first intend to observe the type of inflammation in the gut and lung at prechallenge and post-challenge conditions during the development of AAI in mouse model of asthma.…”
Section: Discussionmentioning
confidence: 99%
“…Type 2 inflammation is known to induce epithelial barrier damage in the gut and lungs. [16,[44][45][46] In UC, IL-13 is observed as a key effector cytokine in inducing intestinal epithelial barrier dysfunction promoting distinct pathogenesis of Th2-driven intestinal inflammation. [47,48] Previous observations in vitro showed epithelial apoptosis and reduced claudin expression mediated by STAT6-activated IL-13 in patients with UC.…”
Asthma is an allergic airway inflammatory disease characterized by type 2 immune responses. Growing evidence suggests an association between allergic airways and intestinal diseases. However, the primary site of disease origin and initial mechanisms involved in the development of allergic airway inflammation (AAI) is not yet understood. Therefore, the initial contributing organs and mechanisms involved in the development of AAI are investigated using a mouse model of asthma. This study, without a local allergen challenge into the lungs, demonstrates a significant increase in intestinal inflammation with signature type‐2 mediators including IL‐4, IL‐13, STAT6, eosinophils, and Th2 cells. In addition, gut leakage and mRNA expressions of gut leakage markers significantly increase in the intestine. Moreover, reduced mRNA expressions of tight junction proteins are observed in gut and interestingly, in lung tissues. Furthermore, in lung tissues, an increased pulmonary barrier permeability and IL‐4 and IL‐13 levels associated with significant increase of lipopolysaccharide‐binding protein (LBP‐gut leakage marker) and eosinophils are observed. However, with local allergen challenges into the lungs, these mechanisms are further enhanced in both gut and lungs. In conclusion, the primary gut originated inflammatory responses translocates into the lungs to orchestrate AAI in a mouse model of asthma.
“…Mouse model of asthma is characterized with AAI developed with i.p OVA sensitization and i.n challenge with OVA in BALB/c mice. This model is characterized by airway inflammation associated with increased type 2 lymphocytes infiltration, eosinophils, alveolar epithelial barrier damage, and mucus secretion by epithelial goblet cells, [2,15,16,32,33] however, the inflammatory manifestations in the gut in not well studied. As observed in several previous studies highlighted the importance of Th2 responses in both gut and lung, we first intend to observe the type of inflammation in the gut and lung at prechallenge and post-challenge conditions during the development of AAI in mouse model of asthma.…”
Section: Discussionmentioning
confidence: 99%
“…Type 2 inflammation is known to induce epithelial barrier damage in the gut and lungs. [16,[44][45][46] In UC, IL-13 is observed as a key effector cytokine in inducing intestinal epithelial barrier dysfunction promoting distinct pathogenesis of Th2-driven intestinal inflammation. [47,48] Previous observations in vitro showed epithelial apoptosis and reduced claudin expression mediated by STAT6-activated IL-13 in patients with UC.…”
Asthma is an allergic airway inflammatory disease characterized by type 2 immune responses. Growing evidence suggests an association between allergic airways and intestinal diseases. However, the primary site of disease origin and initial mechanisms involved in the development of allergic airway inflammation (AAI) is not yet understood. Therefore, the initial contributing organs and mechanisms involved in the development of AAI are investigated using a mouse model of asthma. This study, without a local allergen challenge into the lungs, demonstrates a significant increase in intestinal inflammation with signature type‐2 mediators including IL‐4, IL‐13, STAT6, eosinophils, and Th2 cells. In addition, gut leakage and mRNA expressions of gut leakage markers significantly increase in the intestine. Moreover, reduced mRNA expressions of tight junction proteins are observed in gut and interestingly, in lung tissues. Furthermore, in lung tissues, an increased pulmonary barrier permeability and IL‐4 and IL‐13 levels associated with significant increase of lipopolysaccharide‐binding protein (LBP‐gut leakage marker) and eosinophils are observed. However, with local allergen challenges into the lungs, these mechanisms are further enhanced in both gut and lungs. In conclusion, the primary gut originated inflammatory responses translocates into the lungs to orchestrate AAI in a mouse model of asthma.
“…Keratin, a member of fibrous structural proteins, can protect epithelial cells from stress and damage [ 27 ]. Disruption of epithelial barrier function, such as cornification or keratinization, might result in allergic diseases [ 28 ]. Inoue et al find that downregulation of epithelial defense genes and keratinization occurs in SA mouse sensitized by Alternaria [ 29 ].…”
Background. Severe asthma (SA), a heterogeneous inflammatory disease characterized by immune cell infiltration, is particularly difficult to treat and manage. The airway epithelium is an important tissue in regulating innate and adaptive immunity, and targeting airway epithelial cell may contribute to improving the efficacy of asthma therapy. Methods. Bioinformatics methods were utilized to identify the hub genes and signaling pathways involved in SA. Experiments were performed to determine whether these hub genes and signaling pathways were affected by the differences in immune cell infiltration. Results. The weighted gene coexpression network analysis identified 14 coexpression modules, among which the blue and salmon modules exhibited the strongest associations with SA. The blue module was mainly enriched in actomyosin structure organization and was associated with regulating stem cell pluripotency signaling pathways. The salmon module was mainly involved in cornification, skin development, and glycosphingolipid biosynthesis-lacto and neolacto series. The protein-protein interaction network and module analysis identified 11 hub genes in the key modules. The CIBERSORTx algorithm revealed statistically significant differences in CD8+ T cells (
P
=
0.013
), T follicular helper cells (
P
=
0.002
), resting mast cells (
P
=
0.004
), and neutrophils (
P
=
0.002
) between patients with SA and mild-moderate asthma patients. Pearson’s correlation analysis identified 11 genes that were significantly associated with a variety of immune cells. We further predicted the utility of some potential drugs and validated our results in external datasets. Conclusion. Our results may help provide a better understanding of the relationship between the airway epithelial transcriptome and clinical data of SA. And this study will help to guide the development of SA-targeted molecular therapy.
“…Mucosal surface integrity and mucus secretion in the eye and nose, the upper respiratory tract, the gastrointestinal tract (GIT), and the urogenital tract are critical to impede diffusion and mediate elimination of invaded pollutants. Dysfunctional mucosal epithelial barriers have been associated with antigen invasion, inflammatory activation of epithelial cells, and allergic reactions leading to the development of allergic diseases [11,12]. The GIT that is exposed to the external environment through ingested particles taken up by diet, inhalation, or other interventions exhibits a barrier formed by tightly connected epithelial cells lined with mucus and microbiota.…”
Air pollution and immune-related diseases including allergy and asthma are constantly on the rise worldwide. Thus, a comprehensive investigation of environmentally induced immune regulation is required for a deeper understanding of disease pathogenesis, progression as well as prevention. Here, we summarize the current knowledge on environmental factors such as microbiome or geographical locations with harmful or protective effects for human health and their different routes of exposure. This review comprises a brief outline regarding the latest findings on the interaction of environmental factors with innate and adaptive regulation of the immune system, exemplarily for one protective and one harmful environmental factor, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.